Tandem Total Assets from 2010 to 2024

TNDM Stock

USD 30.74 0.59 1.96%

Tandem Diabetes Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to grow to about 1 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2011-12-31

Previous Quarter

937.5 M

Current Value

957.7 M

Quarterly Volatility

380.4 M

Yuan Drop

Covid

Check Tandem Diabetes financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tandem Diabetes' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8 M, Interest Expense of 6 M or Selling General Administrative of 370.1 M, as well as many indicators such as Price To Sales Ratio of 2.44, Dividend Yield of 0.0 or PTB Ratio of 4.71. Tandem financial statements analysis is a perfect complement when working with Tandem Diabetes Valuation or Volatility modules.

Check out the analysis of Tandem Diabetes Correlation against competitors.

Latest Tandem Diabetes' Total Assets Growth Pattern

Below is the plot of the Total Assets of Tandem Diabetes Care over the last few years. Total assets refers to the total amount of Tandem Diabetes assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tandem Diabetes Care books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Tandem Diabetes' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tandem Diabetes' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 952.66 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Tandem Total Assets Regression Statistics

	Arithmetic Mean	388,599,913
	Geometric Mean	181,878,764
	Coefficient Of Variation	104.52
	Mean Deviation	357,904,844
	Median	162,215,133
	Standard Deviation	406,182,356
	Sample Variance	164984.1T
	Range	1B
	R-Value	0.90
	Mean Square Error	33624.9T
	R-Squared	0.81
	Slope	81,780,491
	Total Sum of Squares	2309777.5T

Tandem Total Assets History

	2024	1 B
	2023	952.7 M
	2022	1.1 B
	2021	905.1 M
	2020	716.4 M
	2019	326.1 M
	2018	206.3 M

Other Fundumenentals of Tandem Diabetes Care

Intangibles To Total Assets

Tandem Diabetes Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Intangible Assets	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.88	0.9	-0.86	0.82	0.99	0.97	0.96	1.0	-0.02	0.78	0.97	0.78	0.56	0.85	0.98	0.93	0.9	0.58	0.6	0.97	0.96	0.97
Total Stockholder Equity	0.88		0.63	-0.76	0.65	0.88	0.9	0.72	0.9	-0.14	0.91	0.77	0.45	0.61	0.89	0.83	0.81	0.9	0.56	0.63	0.92	0.92	0.74
Net Debt	0.9	0.63		-0.79	0.81	0.89	0.87	0.97	0.88	0.21	0.54	0.93	0.89	0.45	0.69	0.89	0.84	0.76	0.56	0.53	0.84	0.84	0.95
Retained Earnings	-0.86	-0.76	-0.79		-0.9	-0.89	-0.81	-0.81	-0.85	-0.19	-0.85	-0.92	-0.78	-0.24	-0.87	-0.84	-0.94	-0.89	-0.78	-0.82	-0.78	-0.78	-0.83
Accounts Payable	0.82	0.65	0.81	-0.9		0.84	0.73	0.83	0.8	0.22	0.72	0.87	0.8	0.11	0.77	0.77	0.87	0.78	0.65	0.67	0.72	0.72	0.81
Net Receivables	0.99	0.88	0.89	-0.89	0.84		0.98	0.94	0.99	-0.01	0.82	0.96	0.76	0.54	0.9	0.97	0.96	0.93	0.66	0.67	0.97	0.97	0.95
Short Term Investments	0.97	0.9	0.87	-0.81	0.73	0.98		0.92	0.99	-0.08	0.78	0.91	0.69	0.67	0.86	0.96	0.9	0.89	0.56	0.59	0.98	0.98	0.93
Total Liab	0.96	0.72	0.97	-0.81	0.83	0.94	0.92		0.94	0.06	0.62	0.97	0.88	0.49	0.76	0.95	0.89	0.83	0.55	0.54	0.91	0.9	0.98
Total Current Assets	1.0	0.9	0.88	-0.85	0.8	0.99	0.99	0.94		-0.05	0.8	0.95	0.74	0.6	0.87	0.97	0.92	0.91	0.58	0.6	0.98	0.98	0.95
Short Term Debt	-0.02	-0.14	0.21	-0.19	0.22	-0.01	-0.08	0.06	-0.05		-0.08	0.09	0.12	-0.19	-0.07	-0.17	-0.03	-0.06	0.23	0.38	-0.08	-0.09	0.0
Common Stock	0.78	0.91	0.54	-0.85	0.72	0.82	0.78	0.62	0.8	-0.08		0.74	0.47	0.35	0.92	0.76	0.84	0.9	0.59	0.76	0.79	0.79	0.66
Property Plant Equipment	0.97	0.77	0.93	-0.92	0.87	0.96	0.91	0.97	0.95	0.09	0.74		0.88	0.42	0.81	0.95	0.93	0.87	0.63	0.63	0.89	0.88	0.98
Current Deferred Revenue	0.78	0.45	0.89	-0.78	0.8	0.76	0.69	0.88	0.74	0.12	0.47	0.88		0.13	0.56	0.81	0.79	0.64	0.47	0.42	0.64	0.63	0.89
Intangible Assets	0.56	0.61	0.45	-0.24	0.11	0.54	0.67	0.49	0.6	-0.19	0.35	0.42	0.13		0.39	0.55	0.35	0.46	0.14	0.17	0.69	0.68	0.49
Long Term Debt	0.85	0.89	0.69	-0.87	0.77	0.9	0.86	0.76	0.87	-0.07	0.92	0.81	0.56	0.39		0.83	0.92	0.97	0.73	0.83	0.89	0.89	0.76
Net Tangible Assets	0.98	0.83	0.89	-0.84	0.77	0.97	0.96	0.95	0.97	-0.17	0.76	0.95	0.81	0.55	0.83		0.93	0.89	0.54	0.53	0.94	0.94	0.97
Long Term Debt Total	0.93	0.81	0.84	-0.94	0.87	0.96	0.9	0.89	0.92	-0.03	0.84	0.93	0.79	0.35	0.92	0.93		0.92	0.7	0.75	0.88	0.88	0.91
Capital Surpluse	0.9	0.9	0.76	-0.89	0.78	0.93	0.89	0.83	0.91	-0.06	0.9	0.87	0.64	0.46	0.97	0.89	0.92		0.73	0.78	0.92	0.92	0.82
Deferred Long Term Liab	0.58	0.56	0.56	-0.78	0.65	0.66	0.56	0.55	0.58	0.23	0.59	0.63	0.47	0.14	0.73	0.54	0.7	0.73		0.8	0.58	0.58	0.54
Short Long Term Debt	0.6	0.63	0.53	-0.82	0.67	0.67	0.59	0.54	0.6	0.38	0.76	0.63	0.42	0.17	0.83	0.53	0.75	0.78	0.8		0.61	0.62	0.51
Net Invested Capital	0.97	0.92	0.84	-0.78	0.72	0.97	0.98	0.91	0.98	-0.08	0.79	0.89	0.64	0.69	0.89	0.94	0.88	0.92	0.58	0.61		1.0	0.9
Net Working Capital	0.96	0.92	0.84	-0.78	0.72	0.97	0.98	0.9	0.98	-0.09	0.79	0.88	0.63	0.68	0.89	0.94	0.88	0.92	0.58	0.62	1.0		0.89
Capital Stock	0.97	0.74	0.95	-0.83	0.81	0.95	0.93	0.98	0.95	0.0	0.66	0.98	0.89	0.49	0.76	0.97	0.91	0.82	0.54	0.51	0.9	0.89

Click cells to compare fundamentals

About Tandem Diabetes Financial Statements

Tandem Diabetes investors utilize fundamental indicators, such as Total Assets, to predict how Tandem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	952.7 M	1 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:

How To Invest In Tandem

Details

Is Tandem Stock a good investment?

Details

What is Tandem Diabetes' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Tandem Diabetes Correlation against competitors.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.37)

Earnings Share

(1.94)

Revenue Per Share

13.082

Quarterly Revenue Growth

0.314

Return On Assets

(0.1)

The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tandem Total Assets from 2010 to 2024

Latest Tandem Diabetes' Total Assets Growth Pattern

Tandem Total Assets Regression Statistics

Tandem Total Assets History

Other Fundumenentals of Tandem Diabetes Care

Tandem Diabetes Total Assets component correlations

About Tandem Diabetes Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY